Through PPI analysis, we identified the top 10 core target genes for XJZT treatment of MDD, including AKT1, albumin, IL-6, TNF, IL-1β, TP53, EGFR, protein c-fos, EGF, and PTGS2. This evidence concerns the gene EGFR and major depressive disorder.